Back to News
Market Impact: 0.55

Nitto Denko H1 Profit Down

NDAQ
Corporate EarningsCompany Fundamentals
Nitto Denko H1 Profit Down

Nitto Denko Corp. reported a decline in financial performance for the six months ended September 30, 2025, with both profit and revenues decreasing year-over-year. Revenues slipped to 513.569 billion yen from 521.723 billion yen, while net profit fell to 68.955 billion yen compared to 80.009 billion yen in the prior year, resulting in diluted earnings per share of 101.28 yen.

Analysis

Nitto Denko Corp. reported a notable decline in its financial performance for the six months ended September 30, 2025. Revenues decreased to 513.569 billion yen from 521.723 billion yen in the prior year, marking a year-over-year contraction in its top-line figures. This revenue slip directly impacted profitability across the period. Net profit for the period fell significantly to 68.955 billion yen, down from 80.009 billion yen last year. Consequently, earnings per share also declined to 101.28 yen from 113.88 yen, reflecting a clear deterioration in the company's fundamental earnings power. These results indicate a strongly negative financial trend for Nitto Denko, aligning with the overall "strongly negative" sentiment signal derived from the report. The moderate market impact score of 0.55 suggests that investors should take note of this performance downturn, which could signal ongoing operational challenges or adverse market conditions impacting the company's core businesses.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly negative

Sentiment Score

-0.60

Ticker Sentiment

NDAQ0.00

Key Decisions for Investors

  • Monitor upcoming earnings reports for any signs of revenue stabilization or profit recovery.
  • Evaluate the underlying factors contributing to the year-over-year decline in both top-line and bottom-line figures.
  • Assess the potential for continued fundamental weakness to impact future valuation and capital allocation decisions.